Cancer and Nanotechnology

Researchers are encouraged to submit abstracts for the "Cancer and Nanotechnology" track at the "World Cancer 2024" conference, focusing on the intersection of nanotechnology and oncology. Abstracts should highlight innovative nanomaterials, nanostructures, and nanomedicines designed for cancer diagnosis, treatment, and theranostics.

Attendees can expect presentations on the latest advancements in nanotechnology-based approaches for cancer imaging, drug delivery, targeted therapy, and theranostics. Discussions will cover topics such as nanoparticle design, surface functionalization, tumor targeting strategies, and controlled drug release mechanisms.

The track will also feature sessions on nanoscale imaging techniques, including nanoparticle-based contrast agents and molecular imaging probes, as well as discussions on safety, toxicity, and regulatory considerations associated with nanotechnology-based cancer therapeutics. Attendees will have the opportunity to engage with leading experts, share insights, and explore collaborative opportunities at the forefront of cancer nanotechnology research.

    Related Conference of Cancer and Nanotechnology

    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    April 07-08, 2025

    15th World Congress on Breast Cancer

    Vancouver, Canada
    April 28-29, 2025

    35th Experts Meet On Cancer Research & Therapy

    Aix-en-Provence, France
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    July 14-15, 2025

    5th World Congress on Breast Cancer

    Berlin, Germany
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain

    Cancer and Nanotechnology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in